Guangxi Huaxi Nonferrous Metal (600301.SH) announces forecasted increase in net profit for 2024, estimated to be between 6.1 billion to 6.8 billion yuan, representing a year-on-year growth of 94.56% to 116.89%.
HuaXi Nonferrous (600301.SH) issued an announcement, expecting to achieve a net profit attributable to the parent company owner in 2024...
Guangxi Huaxi Nonferrous Metal (600301.SH) announced that it is expected to achieve a net profit attributable to the owners of the parent company of 610 million yuan to 680 million yuan in 2024. Compared with the same period last year (statutory disclosure data), it will increase by 2964.78 million yuan to 3664.78 million yuan, with a growth rate of 94.56% to 116.89%; compared with the same period last year (retrospective adjustment), it will increase by 2783.205 million yuan to 3483.205 million yuan, with a growth rate of 83.91% to 105.02%.
It is expected that the net profit attributable to the owners of the parent company excluding non-recurring gains and losses will be 590 million yuan to 650 million yuan in 2024. Compared with the same period last year, it will increase by 2694.87 million yuan to 3294.87 million yuan, with a growth rate of 84.08% to 102.80%.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


